QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Completes Novel Frozen Formulation of Bria-IMT; Announces Participation in Two Upcoming Conferences
BriaCell Therapeutics (OTC: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatments for cancer, today announced multiple updates including completion of its development of a novel frozen formulation of Bria-IMT, its upcoming attendance at the Biotech Showcase taking place Jan. 7-9, 2019 in San Francisco, and the acceptance of an abstract for presentation of advances in Bria-IMT and BriaDX programs at the 2019 Keystone Symposia scientific conference taking place Jan. 20-24, 2019, in Vancouver, British Columbia. According to the update, the new frozen Bria-IMT formulation will provide for on-demand shipment to clinical sites and accommodate higher volumes of patients…